These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12018006)

  • 1. Aromatic as well as aliphatic hydrocarbon solvent axonopathy.
    Spencer PS; Kim MS; Sabri MI
    Int J Hyg Environ Health; 2002 Mar; 205(1-2):131-6. PubMed ID: 12018006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,2-diacetylbenzene, the neurotoxic metabolite of a chromogenic aromatic solvent, induces proximal axonopathy.
    Kim MS; Sabri MI; Miller VH; Kayton RJ; Dixon DA; Spencer PS
    Toxicol Appl Pharmacol; 2001 Dec; 177(2):121-31. PubMed ID: 11740911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotein Targets of γ-Diketone Metabolites of Aliphatic and Aromatic Solvents That Induce Central-Peripheral Axonopathy.
    Spencer PS
    Toxicol Pathol; 2020 Apr; 48(3):411-421. PubMed ID: 32162603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing mechanisms of axonopathy. Part II: Protein targets of 2,5-hexanedione, the neurotoxic metabolite of the aliphatic solvent n-hexane.
    Tshala-Katumbay D; Monterroso V; Kayton R; Lasarev M; Sabri M; Spencer P
    Toxicol Sci; 2009 Feb; 107(2):482-9. PubMed ID: 19033394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyclic and dicyclic hydrocarbons: structural requirements for proximal giant axonopathy.
    Tshala-Katumbay DD; Palmer VS; Lasarev MR; Kayton RJ; Sabri MI; Spencer PS
    Acta Neuropathol; 2006 Sep; 112(3):317-24. PubMed ID: 16874529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo studies of the molecular pathogenesis of n-Hexane neuropathy.
    Graham DG; Anthony DC; Boekelheide K
    Neurobehav Toxicol Teratol; 1982; 4(6):629-34. PubMed ID: 7170020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid and protein targets of 1,2-diacetylbenzene, a potent aromatic gamma-diketone that induces proximal neurofilamentous axonopathy.
    Kim MS; Hashemi SB; Spencer PS; Sabri MI
    Toxicol Appl Pharmacol; 2002 Aug; 183(1):55-65. PubMed ID: 12217642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural studies of the dying-back process. VI. Examination of nerve fibers undergoing giant axonal degeneration in organotypic culture.
    Veronesi B; Peterson ER; Bornstein MB; Spencer PS
    J Neuropathol Exp Neurol; 1983 Mar; 42(2):153-65. PubMed ID: 6827287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new murine model of giant proximal axonopathy.
    Tshala-Katumbay DD; Palmer VS; Kayton RJ; Sabri MI; Spencer PS
    Acta Neuropathol; 2005 Apr; 109(4):405-10. PubMed ID: 15759132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing mechanisms of axonopathy. Part I: Protein targets of 1,2-diacetylbenzene, the neurotoxic metabolite of aromatic solvent 1,2-diethylbenzene.
    Tshala-Katumbay D; Monterroso V; Kayton R; Lasarev M; Sabri M; Spencer P
    Toxicol Sci; 2008 Sep; 105(1):134-41. PubMed ID: 18502740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relevance of axonal swellings and atrophy to gamma-diketone neurotoxicity: a forum position paper.
    LoPachin RM; Lehning EJ
    Neurotoxicology; 1997; 18(1):7-22. PubMed ID: 9215980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental neurotoxicity and urinary metabolites of the C5-C7 aliphatic hydrocarbons used as glue solvents in shoe manufacture.
    Frontali N; Amantini MC; Spagnolo A; Guarcini AM; Saltari MC; Brugnone F; Perbellini L
    Clin Toxicol; 1981 Dec; 18(12):1357-67. PubMed ID: 6277548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenetic studies of hexane and carbon disulfide neurotoxicity.
    Graham DG; Amarnath V; Valentine WM; Pyle SJ; Anthony DC
    Crit Rev Toxicol; 1995; 25(2):91-112. PubMed ID: 7612176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro quantitative structure-activity relationship assessment of pyrrole adducts production by gamma-diketone-forming neurotoxic solvents.
    Sanz P; Flores IC; Soriano T; Repetto G; Repetto M
    Toxicol In Vitro; 1995 Oct; 9(5):783-7. PubMed ID: 20650157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spatio-temporal pattern of the axonopathy associated with the neurotoxicity of 3,4-dimethyl-2,5-hexanedione in the rat.
    Anthony DC; Giangaspero F; Graham DG
    J Neuropathol Exp Neurol; 1983 Sep; 42(5):548-60. PubMed ID: 6310058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory mucosal necrosis in rats following acute intraperitoneal administration of 1,2-diethylbenzene, 1,2-diacetylbenzene and 2,5-hexanedione.
    Gagnaire F; Boucard S
    Neurotoxicology; 2014 Mar; 41():9-19. PubMed ID: 24373906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental neuropathy produced by 2,5-hexanedione--a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone.
    Spencer PS; Schaumburg HH
    J Neurol Neurosurg Psychiatry; 1975 Aug; 38(8):771-5. PubMed ID: 171344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biomarkers of neurotoxic effects induced by environmental chemicals].
    Indulski JA; Lutz W
    Med Pr; 1996; 47(4):383-91. PubMed ID: 8847985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distal axonopathy does not occur without neurofilament accumulation in gamma-diketone neuropathy: comparative studies of normal and neurofilament-deficient quail.
    Hirai T; Mizutani M; Ochiai K; Umemura T; Itakura C
    Acta Neuropathol; 1999 Jun; 97(6):552-6. PubMed ID: 10378373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of hexacarbon-neurotoxicity by methyl-ethyl-ketone (MEK) and other substances: clinical and experimental aspects.
    Altenkirch H; Wagner HM; Stoltenburg-Didinger G; Steppat R
    Neurobehav Toxicol Teratol; 1982; 4(6):623-7. PubMed ID: 7170019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.